The North America High Throughput Screening (HTS) Market is playing a critical role in accelerating drug discovery, biotechnology research, and precision medicine development. As pharmaceutical and biotechnology companies face increasing pressure to develop therapies faster and more efficiently, high throughput screening technologies have become essential tools in modern laboratories.
High...
According to a newly published market research report by 24LifeSciences, the global 3D bioprinting for life science R&D market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.8 billion by 2031, growing at a compound annual growth rate (CAGR) of 18.7% during the forecast period 2025-2031.
3D bioprinting is an innovative manufacturing technique that enables precise...
Cell culture technology plays a fundamental role in modern biotechnology, enabling scientists to study cellular behavior, develop new drugs, and advance regenerative medicine. By growing cells in controlled laboratory environments, researchers can better understand disease mechanisms, evaluate therapeutic effectiveness, and accelerate drug discovery processes. The evolution from traditional 2D...
Cell Surface Market Summary:
According to the latest report published by Data Bridge Market Research, the Cell Surface Market
CAGR Value
Cell Surface Market report has been framed by chewing over an array of market parameters. These factors include but are not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions,...
Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot
CAGR Value
The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period
The research and analysis...
The traditional pharmaceutical landscape is undergoing a radical transformation. For decades, bringing a new drug to market was a marathon often taking over ten years and costing upwards of $2.6 billion, with a failure rate that would make most venture capitalists shudder. Enter Silicon Valley’s favorite protagonist: Artificial Intelligence.
The market was valued at USD 4.46 billion...
The Artificial Intelligence in Drug Discovery Market has transitioned from experimental curiosity to strategic necessity. A decade ago, AI-driven drug discovery felt like a promising research project. Today, it sits at the core of pharmaceutical R&D transformation.
Pharmaceutical companies face rising R&D costs, long development timelines, and high clinical failure rates. According...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek